Pharmacological cardioversion of atrial fibrillation;Medikamentöse kardioversion von vorhofflimmern

Zeitschrift fur Kardiologie

Volumn 94, Issue 1, 2005, Pages 14-22

  Ehrlich, J R ^a   Hohnloser, S H ^a  

^a Abt F Klinische Elektrophysiologie   (Germany)

Author keywords

Amiodarone; Antiarrhythmic drugs; Atrial fibrillation; Cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DOFETILIDE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; SOTALOL;

ANTIARRHYTHMIC ACTIVITY; ANTICOAGULANT THERAPY; CARDIOVERSION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HEART ATRIUM FIBRILLATION; HUMAN; PHARMACOLOGICAL STIMULATION; REVIEW; SINUS RHYTHM; TACHYCARDIA; TORSADE DES POINTES;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CLINICAL TRIALS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS; TREATMENT OUTCOME;

EID: 13344250397     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0166-9     Document Type: Review

References (60)

1. Abi-Mansour P, Carberry PA, McCowan RJ, Henthorn RW, Dunn GH, Perry KT (1998) Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. American Heart Journal 136:632-642
2. Allessie MA, Bonke FI, Schopman FJ (1977) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 41:9-18
3. Alp NJ, Bell JA, Shahi M (2000) Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart 84:37-40
4. Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M (1996) Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol 28:700-706
5. Biffi M, Boriani G, Bronzetti G, Capucci A, Branzi A, Magnani B (1999) Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart 82:176-182
6. Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B (1997) Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med 126:621-625
7. (to) in rapid atrial pacing in rabbits. J Am Coll Cardiol 541:858-869
8. Botto GL, Bonini W, Broffoni T, Molteni S, Lombardi R, Alfieri G, Barone P, Bernasconi G, Ferrari G (1996) Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary? Pacing. Clin Electrophysiol 19:1939-1943
9. Capucci A, Boriani G, Botto GL, Lenzi T, Rubino I, Falcone C, Trisolino G, Della Casa S, Binetti N, Cavazza M (1994) Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 74:503-505
10. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879-1886
11. Chen YJ, Chen SA, Chang MS, Lin CI (2000) Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res 48:265-273
12. Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P (2003) Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 41:255-262
13. Chou, Chung Chuan, Zhou, Shengmei, Miyauchi, Yasushi, Pak, Hui Nam, Okuyama, Yuji, Fishbein, Michael C, Karagueuzian, Hrayr S, Chen, Peng Sheng (2004) Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation. AJP - Heart and Circulatory Physiology 286:H1936-H1945
14. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized trials. Circulation 82:1106-1116
15. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and and the CAST investigators (1991) Mortality and morbidity in patients receiving encainide, felcainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324:781-788
16. Ellenbogen KA, Stambler BS, Wood MA, Sager PT, Wesley RC Jr, Meissner MC, Zoble RG, Wakefield LK, Perry KT, VanderLugt JT (1996) Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 28:130-136
17. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Bettinelli NJ (1987) Digoxin for converting recent onset atrial fibrillation: result of a randomized controlled study. Ann Int Med 106:503-506
18. Falk RH, Pollak A, Singh SN, Friedrich T, and for the intravenous dofetilide investigators (1997) Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Journal of the American College of Cardiology 29:385-390
19. Feinberg W, Blackshear JL, Laupacis A, Kronmal RA, Hart J (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469-473
20. Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD (1983) Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. American Heart Journal 106:501-504
21. Fresco C, Prockmer A, and for the PAFIT 2 Investigators (1996) Management of recent onset atrial fibrillation. Eur Heart J 17:41-47
22. Fuster V, Ryden LE, Asinger et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation): developed in collaboration with the north American society of pacing and electrophysiology. Journal of the American College of Cardiology 38:1231-1266
23. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. N Engl J Med 339: 659-666
24. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492-501
25. Hohnloser SH, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Int Med 121:529-535
26. Hohnloser SH, Singh BN (1995) Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol 6:920-936
27. Hohnloser SH, van de Loo A, Baedeker F (1995) Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 26:852-858
28. Hohnloser SH, Woosley RL (1994) Sotalol. N Engl J Med 331:31-38
29. Jalife J, Berenfeld O, Mansour M (2002) Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res 54:204-216
30. Kawase A, Ikeda T, Nakazawa K, Ashihara T, Namba T, Kubota T, Sugi K, Hirai H (2003) Widening of the excitable gap and enlargement of the core of reentry during atrial fibrillation with a pure sodium channel blocker in canine atria. Circulation 107:905-910
31. Khan IA (2001) Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol 37:542-547
32. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF (2001) Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344:1411-1420
33. Kneller J, Leon J, Nattel S (2001) How do class 1 antiarrhythmic drugs terminate atrial fibrillation? - A quantitative analysis based on a realistic ionic model. Circulation 104:5
34. Kodama I, Kamiya K, Toyama J (1997) Cellular electropharmacology of amiodarone. Cardiovasc Res 35:13-29
35. Li D, Benardeau A, Nattel S (2000) Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation 102:104-112
36. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S (2000) Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101:2631-2638
37. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS (1994) Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23:1535-1540
38. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qi A, Vorderbrugge S, Kerr CR (1990) Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 66:755-757
39. Murgatroyd FD, Gibson SM, Baiyan X, O'Nunain S, Poloniecki JD, Ward DE, Malik M, Camm AJ (1999) Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Circulation 99:2765-2770
40. Murray KT (1998) Ibutilide. Circulation 97:493-497
41. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 15:219-226
42. Nattel S, Hadjis T, Talajic M (1994) The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 48:345-371
43. Nattel S, Singh BN (1999) Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III action. American Journal of Cardiology 84:11R-19R
44. Norgaard BL, Watchell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH, and and the danish dofetilide in atrial fibrillation and flutter study group (1999) Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo controlled trial. American Heart Journal 137:1062-1069
45. Oral H, Souza JJ, Michaud GF, Knight BP, Goyal R, Strickberger SA, Morady F (1999) Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 340:1849-1854
46. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O (2001) Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104:2539-2544
47. Reisinger J, Gatterer E, Heinze G, Wiesinger K, Zeindlhofer E, Gattermeier M, Poelzl G, Kratzer H, Ebner A, Hohenwallner W, Lenz K, Slany J, Kuhn P (1998) Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. American Journal of Cardiology 81:1450-1454
48. Roy D, Talajic M, Dorian P, Connolly SJ, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B, and for the Canadian trial of atrial fibrillation investigators (2000) Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-920
49. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 333:77-82
50. Sopher SM, Camm AJ (1996) Atrial fibrillation: maintenance of sinus rhythm versus rate control. American Journal of Cardiology 77:24A-37A
51. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, Vander-Lugt JT (1996) Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 94:1613-1621
52. Stroobandt R, Stiels B, Hoebrechts R (1997) Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone atrial fibrillation trial investigators. Am J Cardiol 79:418-423
53. Suttorp MJ, Kingma JH, Lie A, Huen, Mast EG (1989) Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 63:693-696
54. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine 347:1825-1833
55. Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, VanderLugt JT, Kowey PR (1998) Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 31:1414-1419
56. Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, Perry KT, Touboul P, Steinbeck G, Wellens HJ (1998) Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 79:568-575
57. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S (1993) Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 88:1030-1044
58. Wijffels MC, Dorland R, Mast F, Allessie MA (2000) Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 102:260-267
59. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81:512-525
60. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S (1999) Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 84:776-784